本页面由Tiger Trade Technology Pte. Ltd.提供服务

PureTech Health PLC

17.61
-0.4810-2.66%
成交量:556.00
成交额:9,891.79
市值:4.23亿
市盈率:10.36
高:17.85
开:17.80
低:17.61
收:18.09
52周最高:20.00
52周最低:13.30
股本:2,402.54万
流通股本:1,624.88万
量比:0.19
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):1.70
每股收益(LYR):0.2103
净资产收益率:9.44%
总资产收益率:-12.95%
市净率:1.13
市盈率(LYR):83.74

数据加载中...

2025/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/12

SEC问询函

Form CORRESP - Correspondence
2024/07/09

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/04

SEC问询函

Form CORRESP - Correspondence
2024/05/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership